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ObMiw. The purpme of Ibis study WIU to era&ate the imnw- 
dixte and follow-up rsults UT permtanews tranvdtrtal mitral cwn. 
mtsswotomy in 6tRl pat&b with rhemnattc mitmt stew&. 
Backgmmzd. Percutaneous tranrstrtat mitral cmnndssurotomy 
kas eme@d as an eflwtive wnnurgical technique for patients 
with symplomstic milrel rtmosts. Several studies have shown that 
the immediate mtd(s are cornpar& to closed and open milml 
v-alvatay. 
1Wef6hfs. Pereutawous tram&al mitral cwnmtwmtomy 
was plrormcd in 660 patimts with rhcumattc mitnd stewsis by 
the dwbk-b&am (m patie& [4S.3%1) aud flowguided inoue 
taltcmn t3ltl patknts [51.7%lr technigues. There were 154 mate 
(25.6%) and 446 femak (77.4%) pattents wltb a mean [+SDI age 
olZ7 f 8 years (range S IO 60). Atria1 fibrillation was present in 
26 patknts (4.3%). mitral i’eSn~itatloo Cgrede 2 in 62 (10.3%) 
and dewety &tSc v&e In 12 tZ%). All pattents had clinicat and 
cdmwrdtograpbtc thwdimensionat, continu0us wwe Doppler, 
edor Ilaw ima&l follow-up at )_month lnterwls. 
After the introduction of percutaneous tmosatrinl mitral 
commissurotomy for treatment of rheumatic mitral stenosis 
hy lnoue et al. (I) in 19S4, followed by Lock et al. in 198.5 (21. 
it has emerged as an effective nonsurgical technique (3-51. 
Closed swSical mitral commissumtomy has been the pre- 
ferred method of treatment For rheumatic mitral stenosis in 
developing countries because it is a safe. effective procedure 
(6-S). Several studies have shown that the results of percu- 
taneous transatrial mitral commirsumtomy we comparable 
to closed (9. IO1 and open mitral commissumtomy (I I). Six 
hundred patients with rheumatic mitral stenosis underwent 
balloon catheter intervention at our center between 1987 and 
1992. We evaluated the immediate and intermediate resuils 
-.- 
3.8 f 4.2 mm Hc (p < 0.M). Mitmt ~~it~tl~ developed or 
incrased in 208 patients (34.6%). Sir patiints (1%) with mitral 
regurgitation reqoired mitral valve replareaie~.t. Cardiac tern. 
pomade occurred in 8 patients (!.3%). Six psttents (1%) died. 
Restenmts developed in 10 patients (1.7%) during a mean f& 
lowup period of37 t S months (rang 6 to 66). 
Con&&m. Percutaneous transatrtat mitral oxmnisss*tomy 
is an e&&e, safe pmeedure with eratifyine intermediate results. 
It should he cons&d the tre!&r.t of choke lor rheumstic 
mitral stenosis. 
(J Aa CoU Car&l 1994;23:1327-321 
of percutanrous transatrial mitral commissumtomy in an 
unselected patient group. 
Methods 
Study group. The study group comprised 603 patients 
with rheumatic mitral stenosis (154 male. 446 female, (mean 
age [tSD] 27 r 8 years, range 8 to6& 527 [87.8%1<30years 
old. 202 [33.6%1 <20 years old). Two hundred sixty-eight 
patients (44.6%) were in New York Heart Association Func- 
tional class IV. 270 (45%) in class 111 and 52 (8.6%) in class 
II. Associated aortic valve disease was present in 26 patients 
(4.3%). Sixty-two patients (10.3%) had mild mitral regurgi- 
tation (sgrade 2). Twenty-six patients (4.3%) bad atrial 
fibrillation. A history of systemic embolism was present in 
four patients (0.7%). Three patients (0.33%) had an orga- 
nired left atrial thrombus (two underwent percutaneous 
transatrial mitral commissurotomy for refractory pulmonary 
edema, and one refused surgical commissurotomy). Seven 
patients (I. 16%) had evidence of rheumatic activity and 
underwent percutaneous tram&al mitral commissurotomy 
because of recurrent episodes of pulmonary edema. Forty- 
two patients (7%) had mitral valve restenosis after closed 
mitral commissurotomy. Eighteen female patients (3%) un- 
da-went the procedure during pregnancy at a mean (*SD) of 
22.2 2 4.3 weeks of gestation (range I2 to 321. A denselv 
(4+) calcific valve waS present in I2 patients (is. Patients 
with mitral regurgitation >grade 2 and left atrial thmmbw 
were exclodd. 
Shady protocol. All patients underwent detailed clinical 
and roen~genologic examination. Echocardiographic (two 
dimensional. continuous wave Doppler and color Row imag- 
ing) examination was done with a 3.S-MHz transducer(CFM 
7SO Vingmed Sound A/G). Mitral valve area was e&dated 
by planimeiry and Doppler pressure half-time. An e&oar- 
diographic scoring system was used to assess the degree of 
rheumatic damage to the mitral valve apparatus (12). Five 
hundred phtienls (83.3%) had an echocardiogmphic score 
~8, and IO0 patients (16.6%) had a score ~9. After 1989. 
single-plane transesophageal echocardiography was per- 
formed using a $-MHz transducer in I) patients suspected to 
have lefl atrial thrombus on transthoracic echocardiography, 
2) during the procedure in patients where ditficulty was 
encountered in septal puncture, and 3) in 50 patients to 
assess the size of the atrial septal defect immediately after 
the orocedure. 
cedures were performed with standby facilities for emer- 
gency closed and open surgical procedures. All patients 
wdement right and left heart catheterization. Cardiac out- 
put was measured by the Fick method. Mitral valve area was 
calculated by the Gorlin formula (13). Left ventricular 
cineangiogmphy was performed in each patient, but in 
pregnant and very sick patients, right heart catheterization 
and left ventricular cineangiography were avoided. Severity 
of mitral regurgitation was graded qualitatively from I + to 
4t (14). Percutaneous transatrial mitral commissurotomy 
WBS performed from a transvenous transscptal approach 
with a wire-guided double-ballwn techniaue (15) in 2SQ 
patients (48.3%) and the Row-guided Inoue bailin tech- 
nique (16) in 310 (51.7%). In the double-balloon technique 
the balloon size was calculated ty the following formula: 
Effective balloon diameter/Body surface area = 21.64 + 2.52 
(mitral valve area index 1.42) (17) and in the lnaue balloon 
technique according to the height of the patient (18). Immc- 
diately after the procedure, balloon catheters were removed. 
and hemodynamic measurements were repeated. All oa- 
tients underwent left ventricular cinear&&phy in the &ht 
anterior oblique projection to evaluate severity of mitral 
regurgitation after the procedure. Patients were discharged 
24 h after the procedure. Optimal valvotomy was defined as 
a mitral valve area of I .5 cn? and an inc&e in mitral valve 
area of at least 25% after valvotomv (41. In 490 oatients . 
angiographically detected mitral regurgitation before and 
after the procedure was analyzed to evaluate th. acidence 
of new, and worsening of existing mitral regurgitation in 
patients with preexisting mild mitral regurgitation. 
Fdkww~. All patients were followed UD at 3.month 
intervals. A de&d echocxdiographic (two dimensional, 
continuous wave Doppler and color flow imaging) assess- 
ment was done at each visit. Mitral valve restenosis was 
defined as a Z50% loss in mitral valve area increase achieved 
or a valve area Cl.5 cm’. or hot\ (17). Patients underwent 
higher or had echocardiognpbic evidence of restenosis. or 
both. Fiiy patients who underwent tmnsesophageal echo- 
cardiography during the procedure for estimation of atrial 
septal defect size and left to right shunt were followed up 
every week for6 months by transesophageal echocardiogm- 
phy. 
Stat&&al Msiv. Analysis of variance was used to 
compare echocardiogmphic and hemodynamic values before 
and after the procedure and results within the subgroups. 
The Speammn rank correlation coefficient was computed for 
determining the relation of various factors to the success of 
percutaneous tmnsatrial mitral commissumtomy. A p value 
<O.OS was considered sianhicant. All values are exwessed 
- as mean value z SD. 
lmwdiate readIs. Percutaneous transalrial mitral com- 
missurotomv was successful in 589 mtienrr NXl%bl. and 
optimal &its were achiived in 562 p&as (93,6%).‘Ki 
WI a increase in mitral valve area from 0.75 2 0.18 to 2.2 ? 
0.38 cm’ (p < 0.001) and a reduction in hansmitral end- 
diitolic gmdicnt from 27.3 + 6. I to 3.8 2 4.2 mm Ha (D < 
0.001). Mcanpllrnauryu(rryprrssurrdecrrasedfo;n42.3 
f. 15.6 to 22.6 f 10.5 mm HE lo E: 0.001). CanSac index 
increased from 3.5 + I1 to 4.i; I.4 litersl’mi~ per m* (p 4 
0.01). The procedure was optimal in all pregnant women 
(Fig. I). in all patients with mitral valve resten& (Fii. 2) 
and in all patients with densely cakhlc valves (Fig. 3). There 
was no inlluence of age. predilalion mitral valve area index 
or dcgra of subvalvular patholooy on mitral valve wea 
achieved after percutaneous tmnsatrial mitral commissumt- 
omy. Patients had signibam symptomatic improvemen* 
after the wocedure (3% l59.3%1 were in functional claw 1. 
215 135.8&I in class~ll. lb [3.l;%] in class Ill). The pm& 
due could not be completed in I I patients (1.8%) because of 
inability to perform septal punclure in 2, failure to cross the 
mitral valve in I and procedure-related complications in 8. 
Doubte-Wow verw Iawe baUca IecUque. Camper- 
ative analysis of IWO large patient groups with nearly equal 
number; revealed that both techniques are equally effective 
(Table I). The incidence of mitral ~regurgitat~on ias hiir 
with the lnoue balloon technique (44%) compared with the 
double-balloon technique (25%). Fluomscop’c time was less 
with the lnoue balloon technique (I8 t 7 min) compared 
with the double-balloon technique (34 C 14.8 min. p c 0.01). 
In pregnant women fluomscopic time could be kept as low as 
F&we 1. Hcmodynemic effects of ue~ui~lie~us traurawial mitr.ll 
ccmmtissurotomy @etched tcus) in preatxutt and nonpreanonr pa- 
tients. S& bus = baseline. 
6. I +  2.2 min with the lnoue balloon technique (p < 0.01). In 
three patients the mitral valve could not be crossed with the 
Ioottc balloon technique. In two of these patients the proce- 
dure was successfdly completed by the double-balloon 
tccboiquc. 
Complintlotts. Cardiac ramponade. Eight patienw 
(I .3%) had cardiac tamponade &ring the procedure because 
of left attial perforation (six patients) and left venlticuler teat 
(WO patients). Tb= i& ventricular tear Was successfully 
F&m 2. Hcmadynamic etrectr of percutaneous transatrial mitral 
commissurotomy in patients with and sitbout restenosis. Symbols 
as in Fire I. 
repaired with a pericardial patch in both the patients. One 
patient died on the third postoperative day because of 
disseminated intravascular coagulopathy. Left atria: p&o- 
ration was detected in six patients and was repaired in all, 
followed by successful closed mitral commissurotomy. 
However. four patients died minglhe postoperative period. 
Mirrnl regargifation. Mitral regurgitation appeared or 
wonened in 208 patients (34.6%) (72 patients IZS%] with the 
double-balloon technique and I36 I44101 with the Inoue 
balloon technique). Significant regurgitation requiring mitral 
valve replacement. however, occurred in only six patients 
(1%). Four patients uudenvent emergency mitral valve re- 
placement (one patient died during the postoperative period 
within 24 h). and two required mitral vnlve replacement at 3 
and 8 months after (he pro&ure. Analysis of mitral regur- 
gitation in 490 patients after percutaneous transattial mitral 
commtssurmomy revealed the appearance of new. and an 
utcrease in preexisting, mitral &gurgitation in 143 patients 
(29.2%). und the dearze of chanse is shown in Fiaurc 4. 
None ofthr morphoh&. technicaio-patientchatact&istics 
studied predicted the development of mitral regurgitation 
after balloon dilation (19). 
Sysfcmic rmboiizatioa. Two patients developed a cere- 
brovascular accident. and one developed left femoral artery 
embolization immediately after the pmcedure. Ail were in 
normal siws rhythm, aid none had evidence of left atriil 
thrombus on transthoracic two-dimensional echocardio- 
graphic examination done before the procedure. 
Alrial seprol defect. Atrial septal defect (I to 2 root in 
diameter) was seen in 46 (92%) of 50 oatients who had 
transerophageal echocardiography immediately after percu- 
taneous tnnsuttial mitral commissurotomy. At 6 months it 
persisted in only 4%. and the mean closure time was 4.6 * 
2.2 weeks. as reported earlier (20). 
F&w-up. All patients except IO with a successful pro. 
cedure have had regular clinical and echocardiographic 
follow-up (mean follow-up 37 f 6 months. range 6 to 66). Of 
400 patients with follow-up >I? months, 250 had the proce- 
dure 236 months previously. Echocardiographic restenosis 
was observed in IO (2%) patients. Two patients with resten- 
osis had dense calcification of the mitral valve. Only six of 
these uatients had svmutoms. None of the patients without 
any &deuce of r&n&is had worsening if symptoms on 
followup. Percutaneous transattial mitral commissurotomy 
was successfully repeated in two patients. One patient had to 
undergo closed mitral commissurotomy because of inferior 
vena caval thrombosis. 
Discussion 
Mitral s!enosisinIndiaalfectsayoun&rpopulation in the 
prime of life, andamajority ofthe patients with symptomatic 
mural stenosis present <30 years of age (5.6). Percutaneous 
transatnal mitral commissurotomy is emerging as en effec- 
tive treatment option in patiects with symptomatic mitral 
valve stenosis. After the procedure was initially performed 
by Iwue et al. (11, the technique evolved rapidly. Several 
investigators have reparted improved haemodynamic status 
and low procedure-relaled mortalily (Z-5). 
Immediate vaults. In our series, optimal valvotomy was 
achieved in 562 patients (93.6%). T’ nemodynamic im- 
provement obtained in our patients IS comparable to the 
results reported elsewhere (Z-5). Among the various factors 
analyzed for determining the success of percutaneous 
transatrial mitral commissurotomy (age, valve morphology, 
baseline miwal valve area). none weR predictive of OUI- 
come. This is in contrast to &dings of other studies where 
ecbocardiographic valve morphology was &led to final 
mitral valve area after percutaneous transatrial mitral com- 
missurotomy (4,211. C&w et al. (22) have reported similar 
immediate increases in mitral valve area irrespective of 
T&k I. Double-Balloon Versus lnoue Balloon Tecbniaue 
predilalian valvular or subvalvular pathology or calcifica- 
don. The National Hean, Lung, and Blood lnrtilute (23) 
balloon valvuloplasty registry found a weak comladon 
between mitral valve mmpbo~ ar arxssed by echoedi- 
ogmphy and increase in mitral valve area. Fiegenbaum et al. 
(24) showed better results in younger patients. 
lmmed~~hdiUaa~nlqorp.Thepmcedun 
was successful in all pregnant patients, with no adverse 
eLcls lo the feas. Fluoroxopic time could be kept as low 
as 6.1 f 2.2 min in these patients. The abdomen WBO 
shielded with lead IO minimize radiidon, wd cincangiwra- 
phy was avoided. The present study and previous owes 
(25,26) in prcgnanl ptierds have clearly shown ti Ihis 
pmcedure iseffective. whh noadversee#etisto the fetus, in 
contrast to surgical commissurotomy, wbiih is associated 
with higb fetal loss (27.28). The effectiveness of balloon 
dilation in all patients whh milral valve renenosin in the 
present study is comparable to previous studier (29.30). We 
achieved optimal results in all patients with densely c&tic 
valves. This is contrary to the study by Hennan et al. (31) 
who reported that calcified valves are more resistant to 
balloon dilation. There were only I2 patients in OUT study 
with dense calcificarion of the mitral valve. More experience 
in patients with calchic mitral stenosis is needed before a 
definite opinion can be given with regard to this subgroup. 
Doable- veraas sin@balloon technique. Several opera- 
tors have found similar hemodynamic results with the dou- 
ble-balloon and Inoue balloat techniques (32.33). Chen et al. 
(32) reported a lesser incidence of mitral regurgitation with 
the tnoue balloon technique compared with the double- 
balloon technique (15.7% vs 5G%, respectively). In contrast. 
Bassand et al. (33) reported a relatively higher incidence of 
mild mitral regurgitation with the li:a~ balloon technique, 
but the incidence of severe mitral regurgitation was similar 
with both techniques. In our study there was n statistically 
signil&tt increase ill the incidence of mitral regurgitation 
with the lnoue ballwn technique compared with the double- 
balloon technique. Percutaneous transatrial mitral commis- 
surotomy is easier to p&on using the lnoue balloon 
technique and requires a shorter tluoroscopic time. This is 
similar to the experience reported in other studies (26.27). 
The shorter fluoroscopic time makes the lnoue balloon 
technique more useful in performing balloon mitral commis- 
sumtomy in pregnant patients. 
Cawfkatbns. Cardiac tamponade secondary to inad- 
vetlent ~eptal puncture was the major complication in our 
patients. Four of six patients who developed left atria1 
oerfomtion died. All of the deaths occurred in the first IGil 
imtiettts in the series. All of these patients were managed 
with immediate pericardiocentesis as soa as the cardiac 
tanqwade was diagnosed, but there was a delay in seeking 
surgical help that resulted in bii mortality. 
Orgamk& left atrial thmmbw. In three patients with 
organized left atrial thrombus away from the inter&al 
septum. we were able to do a successful procedure with the 
Ithwe balloon aRer adequate anticoagulation for 3 weeks. 
Two of these patients had gross congestive heart failure and 
were considered to he at high surgical risk for open heart 
surgery. Om patient refused open heart surgery. At present 
we do not recommend this procedure QS a routine for all 
patients with organized left atrial tbrombus, but in very sick 
patients it is a possible alternative to open mitral commis- 
surotomy. 
itok d trmwaepw ceboesr~mphy. Percutaneous 
transatrinl mitral commisswotomy has lately been aided by 
ttansesophageal echocardiography as an additional imaging 
modality. It is of help in interatria! septal puncture in the 
occasional patient with distorted septal anatomy (34). We 
needed tramesophageal echowdiography in three of our 
patients to pelfoml the septal puncture. 
Re+tao&. The incidence of restenosis after surgical 
commissumtomy is 2% to 6iYZ (35-37). In most of these 
studies patients were evaluated only on clinical basis. which 
may explain the inconsistency in the reported incidence of 
restenosis. In one of tne studies that followed up patients by 
estimation of miwzd valve area by two-dimensional echocar- 
diography in I8 patients, 5 had restenasis at IO years of 
follow-up (;hl. Follow-up in B recent series of patients with 
percutaneous trmsatrial mitral commissurotomy is by echo- 
cardiography (38-42). In our study 98% of the patients had 
regular clinical and echocardiogmphic follow-up atIer the 
procedure, and the incidence of restenosis was only 2% at 37 
+ 8 months. Two (16.6%) of I2 patients wilh g densely 
calcified valve developed restenosis. Compared with the 
total group the incidence of restenosis appears Inigh, but it 
difficult to draw conclusions because there were fewer 
patients in this subgroup. Studies of balloon mitral commis- 
SU~O~O~Y in younger patients have shown a lower restenosis 
rate (38-40). whereas studies in older patients have shown a 
hieher restenosis rate 141.421 lTablc 2). 
~Conclusions. PercutanLo~s‘transat& mitral commissur- 
otamy is an effective, safe procedure. with gratifying inter- 
medlale results. It should be considered the treatment of 
choice in patients with rheumatic mitral stenosis. 
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